Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,947 | 184 | 90.9% |
| Education | $241.21 | 10 | 7.4% |
| Unspecified | $52.80 | 1 | 1.6% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $359.45 | 22 | $0 (2019) |
| Janssen Biotech, Inc. | $321.55 | 17 | $0 (2019) |
| PFIZER INC. | $307.32 | 23 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $256.47 | 17 | $0 (2019) |
| Lilly USA, LLC | $155.64 | 11 | $0 (2019) |
| Celgene Corporation | $137.14 | 6 | $0 (2019) |
| Genentech USA, Inc. | $136.94 | 8 | $0 (2019) |
| EISAI INC. | $126.52 | 7 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $112.23 | 2 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $105.66 | 8 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $11.92 | 1 | Gilead Sciences, Inc. ($11.92) |
| 2019 | $842.41 | 48 | Janssen Biotech, Inc. ($124.11) |
| 2018 | $1,174 | 76 | Novartis Pharmaceuticals Corporation ($152.75) |
| 2017 | $1,213 | 70 | Novartis Pharmaceuticals Corporation ($140.47) |
All Payment Transactions
195 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 11/08/2019 | Array BioPharma Inc. | Braftovi (Drug), Mektovi | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Melanoma | ||||||
| 09/04/2019 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug), TASIGNA | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: ONCOLOGY | ||||||
| 08/23/2019 | Janssen Biotech, Inc. | DARZALEX (Biological), IMBRUVICA | Food and Beverage | In-kind items and services | $33.38 | General |
| Category: Oncology | ||||||
| 08/20/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: ONCOLOGY | ||||||
| 08/16/2019 | EMD Serono, Inc. | Bavencio (Biological) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: Oncology | ||||||
| 08/02/2019 | EISAI INC. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $16.45 | General |
| Category: Oncology | ||||||
| 08/02/2019 | EISAI INC. | Lenvima (Drug) | Education | Cash or cash equivalent | $13.37 | General |
| Category: Oncology | ||||||
| 07/31/2019 | JAZZ PHARMACEUTICALS INC. | VYXEOS (Drug) | Food and Beverage | In-kind items and services | $12.40 | General |
| Category: ONCOLOGY | ||||||
| 07/30/2019 | Astellas Pharma US Inc | XOSPATA (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: ONCOLOGY | ||||||
| 07/24/2019 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: Oncology | ||||||
| 07/12/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: Oncology | ||||||
| 07/02/2019 | PFIZER INC. | MYLOTARG (Biological), BOSULIF, BESPONSA | Food and Beverage | In-kind items and services | $12.39 | General |
| Category: ONCOLOGY | ||||||
| 06/26/2019 | Amgen Inc. | Kyprolis (Biological), XGEVA | Food and Beverage | In-kind items and services | $27.28 | General |
| Category: Oncology | ||||||
| 06/19/2019 | Janssen Biotech, Inc. | Erleada (Drug), DARZALEX | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Oncology | ||||||
| 06/18/2019 | Bayer HealthCare Pharmaceuticals Inc. | Vitrakvi (Drug) | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: Oncology | ||||||
| 06/05/2019 | Novartis Pharmaceuticals Corporation | PIQRAY (Drug), SANDOSTATIN, VOTRIENT | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: ONCOLOGY | ||||||
| 06/04/2019 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: Oncology | ||||||
| 05/28/2019 | Eli Lilly and Company | — | — | In-kind items and services | $52.80 | Research |
| Study: RANDOMIZED STUDY OF AM0010 IN COMBINATION WITH FOLFOX COMPARED TO FOLFOX ALONE AS SECOND-LINE TX IN PTS WITH META PANCREATIC CANCER THAT HAS PROGRESSED DURING OR FOLLOWING A FIRST-LINE GEMCITABINE CONTAINING REGIMEN | ||||||
| 05/22/2019 | E.R. Squibb & Sons, L.L.C. | EMPLICITI (Biological) | Food and Beverage | Cash or cash equivalent | $15.26 | General |
| Category: Oncology | ||||||
| 05/17/2019 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.24 | General |
| 05/15/2019 | Ipsen Biopharmaceuticals, Inc | SOMATULINE DEPOT (Drug), ONIVYDE | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Oncology/Endocrinology | ||||||
| 05/09/2019 | Clovis Oncology, Inc. | Rubraca (Drug) | Education | In-kind items and services | $10.20 | General |
| Category: Oncology | ||||||
| 05/07/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: ONCOLOGY | ||||||
| 04/17/2019 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $13.36 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| RANDOMIZED STUDY OF AM0010 IN COMBINATION WITH FOLFOX COMPARED TO FOLFOX ALONE AS SECOND-LINE TX IN PTS WITH META PANCREATIC CANCER THAT HAS PROGRESSED DURING OR FOLLOWING A FIRST-LINE GEMCITABINE CONTAINING REGIMEN | Eli Lilly and Company | $52.80 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 22 | 37 | $9,206 | $3,262 |
All Medicare Procedures & Services
1 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 22 | 37 | $9,206 | $3,262 | 35.4% |
About Kerry Pulver, MD,PHD
Kerry Pulver, MD,PHD is a Hematology & Oncology healthcare provider based in Boise, Idaho. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1376596247.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kerry Pulver, MD,PHD has received a total of $3,241 in payments from pharmaceutical and medical device companies, with $11.92 received in 2021. These payments were reported across 195 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($2,947).
As a Medicare-enrolled provider, Pulver has provided services to 22 Medicare beneficiaries, totaling 37 services with total Medicare billing of $3,262. Data is available for 1 year (2023–2023), covering 1 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Location Boise, ID
- Active Since 05/19/2006
- Last Updated 05/22/2013
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1376596247
Products in Payments
- OPDIVO (Biological) $194.06
- CYRAMZA (Drug) $130.13
- Erleada (Drug) $99.89
- ZALTRAP (Drug) $99.00
- Kyprolis (Biological) $91.01
- AFINITOR (Drug) $87.56
- Lenvima (Drug) $79.88
- DARZALEX (Biological) $78.80
- KEYTRUDA (Biological) $77.94
- Revlimid (Drug) $75.90
- ZYTIGA (Drug) $72.53
- Imbruvica (Drug) $71.85
- IMBRUVICA (Drug) $70.33
- VOTRIENT (Drug) $62.10
- Abraxane (Drug) $61.24
- IBRANCE (Drug) $60.90
- MYLOTARG (Drug) $57.04
- XALKORI (Drug) $56.84
- INJECTAFER (Drug) $55.21
- GILOTRIF (Drug) $53.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Boise
Dr. Cannon Milani, Md, MD
Hematology & Oncology — Payments: $6,519
Dr. Olga Derman, M.d, M.D
Hematology & Oncology — Payments: $4,704
Andrew Pierson, Md, MD
Hematology & Oncology — Payments: $4,586
William Kreisle, Md, MD
Hematology & Oncology — Payments: $1,081
Shane Ahlers, M.d, M.D
Hematology & Oncology — Payments: $787.10
Dan Zuckerman, Md, MD
Hematology & Oncology — Payments: $716.63